Targeted gene therapy of xeroderma pigmentosum cells using meganuclease and TALEN™.
Xeroderma pigmentosum group C (XP-C) is a rare human syndrome characterized by hypersensitivity to UV light and a dramatic predisposition to skin neoplasms. XP-C cells are deficient in the nucleotide excision repair (NER) pathway, a complex process involved in the recognition and removal of DNA lesi...
Guardado en:
Autores principales: | Aurélie Dupuy, Julien Valton, Sophie Leduc, Jacques Armier, Roman Galetto, Agnès Gouble, Céline Lebuhotel, Anne Stary, Frédéric Pâques, Philippe Duchateau, Alain Sarasin, Fayza Daboussi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/43fe12d192c34e43908b529a3573f188 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Xeroderma Pigmentosum
por: SEPULVEDA R,DARIO
Publicado: (1950) -
Xeroderma Pigmentosum: General Aspects and Management
por: Monica Piccione, et al.
Publicado: (2021) -
Mitochondrial targeted meganuclease as a platform to eliminate mutant mtDNA in vivo
por: Ugne Zekonyte, et al.
Publicado: (2021) -
High frequency targeted mutagenesis using engineered endonucleases and DNA-end processing enzymes.
por: Fabien Delacôte, et al.
Publicado: (2013) -
TALEN outperforms Cas9 in editing heterochromatin target sites
por: Surbhi Jain, et al.
Publicado: (2021)